Certificate Program PDF Print Email

The 2012 Application period is closed. 
Check back for details on the 2013 International Certificate Program.


4th Annual International Certificate Program
May 6 - May 12, 2012 • Siracusa, Italy



2012 Curriculum    (draft 2012 curriculum)  

Translational medicine encompasses the continuum from identifying an idea to its development into new therapies for human diseases. By enabling people to develop research through this continuum, we will move critical scientific insights into tangible benefits for patients. The Program is offered by the Eureka Institute for Translational Medicine.


Over an intensive 7-days, we will examine case studies, and help you develop creative problem solving strategies and novel skills to build new kinds of teams. You’ll also hone your ability to communicate effectively across broad audiences. The certificate program is tailored to individual needs, and is based on learner-centered discussions and mentoring by internationally recognized leaders. Skills garnered from this course will help individuals and team members to address the challenges facing drug development today, and bridge the divide between concept and patient.


Course Topics

  • The concept and components of Translational Medicine
  • Intellectual property protection and development
  • Funding (public versus private)
  • Publication
  • Regulatory issues
  • Research ethics
  • Data management and statistical strategies
  • Academia and industry partnerships
  • From mountains to molehills: transforming basic research into leads
  • Modeling diseases and therapies in experimental systems
  • Clinical trial design
  • Managing research groups
  • International issues
  • Animal models
  • Refined approach: from global diseases to individualized care


Overall Educational Objectives

    Participants will:
  • Analyze the business, scientific and regulatory aspects of Translational Medicine (TM)
  • Explore the challenges professionals encounter in TM
  • Develop critical thinking skills to approach the challenges in TM
  • Develop communication skills for presenting complex scientific ideas to a broad spectrum of people
  • Analyze effective manuscript preparation and begin to apply the concepts to their own work


2012 Faculty and Keynote Roster

Confirmed

  • Salvatore Albani, M.D., Ph.D., Professor and Director, Translational Medicine, Infectious and Inflammatory Diseases, Sanford-Burnham Medical Research Institute
  • Hans-Georg Eichler, M.D., M.Sc., Senior Medical Officer, European Medicines Agency
  • Dirk Elewaut, M.D., Ph.D., Professor of Rheumatology and Immunology; Head, Laboratory for Molecular Immunology and Inflammation; Division of Rheumatology, a EULAR and FOCIS Center of Excellence; Ghent University Hospital 
  • Napoleone Ferrara, Ph.D., Genentech Fellow, Tumor Biology and Angiogenesis, Research Oncology, Genentech, Inc. 
  • Wainwright Fishburn, J.D., Partner, Cooley Godward Kronish LLP
  • David Hafler, M.D., Ph.D., Chief and Chair of Neurology, Yale New Haven Hospital and Yale School of Medicine
  • Janet Hafler, Ed.D., Assistant Dean for Educational Scholarship, Yale School of Medicne
  • Johan Garssen, M.D., Ph.D., Professor, Immunopharmacology, the University of Utrecht; and Director, Immunology, Danone Research Centre for Specialized Nutrition, Wageningen, the Netherlands
  • Carol Gregorio, Ph.D., Professor of Cell Biology and Anatomy, and Molecular and Cellular Biology; Member, BIO5 Institute; Director, Molecular Cardiovascular Research Program; Co-Director, Sarver Heart Center, The University of Arizona
  • Juan Carlos Lopez, Ph.D., Editor-in-Chief, Nature Medicine
  • Allan Kaplan, M.Sc., M.D., FRCP(C), Vice Chair Research, Department of Psychiatry, Director, Institute of Medical Science, Professor of Psychiatry, University of Toronto
  • Paul Krieg, Ph.D., Professor of Cell Biology and Anatomy and Molecular and Cellular Biology, The University of Arizona
  • Patrick Maxwell, M.D., Ph.D., Professor, Metabolism and Experimental Therapeutics, Dean of Medical Science, University College London, United Kingdom
  • Berent Prakken, M.D., Ph.D., Professor of Pediatric Immunology at the University Medical Centre Utrecht, the Netherlands; Chair, EULAR
  • Maria Grazia Roncarolo, M.D., Ph.D., Scientific Director, San Raffaele Scientific Institute; Professor of Pediatrics, School of Medicine and Surgery, San Raffaele Vita-Salute University; Chief of Clinic, Pediatric Immunology and Hematology and Clinical Research Unit (CRU-P) San Raffaele Hospital and San Raffaele Scientific Institute, Milan, Italy
  • Norm Rosenblum, M.D., Professor of Paediatrics, Canada Research Chair in Developmental Nephrology, and Associate Dean, Physician Scientist Training, University of Toronto
  • Vicki Seyfert-Margolis, Ph.D., Food and Drug Administration
  • Jeffrey Siegel, M.D., Senior Group Medical Director, Product Development Inflammation, Genentech, Inc.
  • Lucy Wedderburn, M.D., Ph.D., Professor of Pediatric Rheumatology at the University College London, United Kingdom

 

Tentative

  • Luca Guidotti, M.D., Ph.D., Director, Diabetes Research Institute, Head Immunopathogenesis of Liver Infections Unit, San Raffaele Scientific Institute; Associate Professor, Department of Immunology & Microbial Sciences, The Scripps Research Institute
  • Jingwu Zang, Ph.D., GSK R&D China


How to Apply

To apply for the course, please submit the following*:

  • Contact information
  • CV (curriculum vitae)
  • Letter of support from your supervisor
  • A brief statement of your needs and expectations of the course

Submit To: info[at]eurekainstitute[dot]org or fax to Attn: Jessica, Eureka May 2012 at 001 (858) 795-5225.

*All materials must be received in order to be considered for attendance.



Tuition^: €2500
^The registration fee includes course materials, all lunches, breaks, and transportation from and to the Catania International Airport. Scholarships may be available. Please inquire. Contact us if you have any questions about the program.